View Item 

Show simple item record

Practice guidelines for prenatal and perinatal immunohematology, revisited

dc.contributor.authorJudd, W. Johnen_US
dc.date.accessioned2010-06-01T20:40:23Z
dc.date.available2010-06-01T20:40:23Z
dc.date.issued2001-11en_US
dc.identifier.citationJudd, W. John (2001). "Practice guidelines for prenatal and perinatal immunohematology, revisited." Transfusion 41(11): 1445-1452. <http://hdl.handle.net/2027.42/73778>en_US
dc.identifier.issn0041-1132en_US
dc.identifier.issn1537-2995en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73778
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11724993&dopt=citationen_US
dc.format.extent86749 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Incen_US
dc.rights2001 American Association of Blood Banksen_US
dc.subject.otherCLT = Chemiluminescence Testen_US
dc.subject.otherFMH = Feto-maternal Hemorrhageen_US
dc.subject.otherMMA = Monocyte Monolayer Assayen_US
dc.subject.otherRhIg = Rh Immune Globulinen_US
dc.subject.otherSSCC = Scientific Section Coordinating Committee.en_US
dc.titlePractice guidelines for prenatal and perinatal immunohematology, revisiteden_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumFrom the Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan.en_US
dc.identifier.pmid11724993en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73778/1/j.1537-2995.2001.41111445.x.pdf
dc.identifier.doi10.1046/j.1537-2995.2001.41111445.xen_US
dc.identifier.sourceTransfusionen_US
dc.identifier.citedreferenceJudd WJ, Luban NLC, Ness PM, et al. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 1990; 30: 175 83.en_US
dc.identifier.citedreferenceQueenan JT, Tomai TP, Ural SH, King JC. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: a proposal for clinical management. Am J Obstet Gynecol 1993; 168: 1370 6.en_US
dc.identifier.citedreference3. Prevention of hemolytic disease of the newborn due to anti-D. Association Bulletin 98-2. Bethesda: AABB, February 16, 1998.en_US
dc.identifier.citedreferenceVengelen-Tyler V, ed.. Technical manual. 13th ed. Bethesda: American Association of Blood Banks, 1999.en_US
dc.identifier.citedreferenceMenitove JE, ed.. Standards for blood banks and transfusion services. 19th ed. Bethesda: American Association of Blood Banks, 1999.en_US
dc.identifier.citedreferenceSebring ES, Polesky HF. Detection of fetal maternal hemorrhage in Rh immune globulin candidates. A rosetting technique using enzyme-treated Rh 2 Rh 2 indicator erythrocytes. Transfusion 1982; 22: 468 71.en_US
dc.identifier.citedreferenceButch SH, Judd WJ. Simplified protocol for screening Rh immune globulin candidates (abstract). Transfusion 1983; 23: 440.en_US
dc.identifier.citedreferenceLubenko A, Contreras M, Habash J. Should anti-Rh immunoglobulin be given to D variant women? Br J Haematol 1989; 72: 429 33.en_US
dc.identifier.citedreferenceWagner FF, Kasulke D, Kerowgan M, Flegel WA. Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany. Infusionsther Transfusionsmed 1995; 22: 285 90.en_US
dc.identifier.citedreferenceBowman JM, Chown B, Lewis M, Pollock JM. Rh isoimmunization during pregnancy: antenatal prophylaxis. CMAJ 1978; 118: 623 7.en_US
dc.identifier.citedreference11. Clinical management for obstetricians-gynecologists. ACOG Practice Bulletin Number 4. Washington: American College of Obstetricians and Gynecologists, 1999.en_US
dc.identifier.citedreferenceRothenberg JM, Weirermiller B, Dirig K, et al. Is a third-trimester antibody screen in Rh+ women necessary? Am J Manag Care 1999; 5: 1145 50.en_US
dc.identifier.citedreferenceHeddle NM, Klama L, Frassetto R, et al. A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion 1993; 23: 217 20.en_US
dc.identifier.citedreferenceShulman IA, Calderon C, Nelson JM, Nakayama R. The routine use of Rh-negative reagent red cells for the identification of anti-D and the detection of non-D red cell antibodies. Transfusion 1994; 34: 666 70.en_US
dc.identifier.citedreferenceReid ME, Chandrasekaran V, Sausais L, et al. Disappearance of antibodies to Cromer blood group system antigens during mid pregnancy. Vox Sang 1996; 71: 48 50.en_US
dc.identifier.citedreferenceSmith ML, Beck ML. The immunoglobulin structure of human anti-M agglutinins. Transfusion 1979; 19: 472 4.en_US
dc.identifier.citedreferenceReid ME, Lomas-Francis C. The blood group antigen FactsBook. San Diego: Academic Press, 1997: 32.en_US
dc.identifier.citedreferenceBowman JM, Pollock JM. Amniotic fluid spectrophotometry and early delivery in the management of erythroblastosis fetalis. Pediatrics 1965; 35: 815 9.en_US
dc.identifier.citedreferenceWeiner CP, Williamson RA, Wenstrom KD, et al. Management of fetal hemolytic disease by cordocentesis. I. Prediction of fetal anemia. Am J Obstet Gynecol 1991; 165: 546 53.en_US
dc.identifier.citedreferenceWade RV. Images, imagination and ideas: a perspective on the impact of ultrasonography on the practice of obstetrics and gynecology. Presidential address. Am J Obstet Gynecol 1999; 181: 235 9.en_US
dc.identifier.citedreferenceMari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000; 342: 9 14.en_US
dc.identifier.citedreferenceQueenan JT. Modern management of the Rh problem. 2nd ed. Hagerstown, MD: Harper and Row, 1977.en_US
dc.identifier.citedreferenceFreda VJ. The Rh problem in obstetrics and a new concept of its management using amniocentesis and spectrophotometric scanning of amniotic fluid. Am J Obstet Gynecol 1965; 92: 341 74.en_US
dc.identifier.citedreferenceSazama K. Comprehensive transfusion medicine survey J-C, final critique. Chicago: College of American Pathologists, 1995.en_US
dc.identifier.citedreferenceLapierre Y, Rigal D, Adam J, et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990; 30: 109 13.en_US
dc.identifier.citedreferenceSpinnato JA. Hemolytic disease of the fetus: a plea for restraint. Obstet Gynecol 1992; 80: 873 7.en_US
dc.identifier.citedreferenceGoodrick MJ, Hadley AG, Poole G. Haemolytic disease of the fetus and newborn due to anti-Fy a and the potential clinical value of Duffy genotyping in pregnancies at risk. Transfus Med 1997; 7: 301 4.en_US
dc.identifier.citedreferenceVaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998; 338: 798 803.en_US
dc.identifier.citedreferenceShirey RS, Mirabella DC, Lumadue JA, Ness PM. Differentiation of anti-D, -C, and -G: clinical relevance in alloimmunized pregnancies. Transfusion 1997; 37: 493 6.en_US
dc.identifier.citedreferenceJudd WJ. Methods in immunohematology. 2nd ed. Durham, NC: Montgomery Scientific Publications, 1994.en_US
dc.identifier.citedreferenceVan Dijk BA, Dooren MC, Overbeeke MA. Red cell antibodies in pregnancy: there is no critical titre. Transfus Med 1995; 5: 199 202.en_US
dc.identifier.citedreferenceEngelfreit CP, Reesink HW, Bowman J, et al. Laboratory procedures for the prediction of the severity of haemolytic disease of the newborn. Vox Sang 1995; 69: 61 9.en_US
dc.identifier.citedreferenceLucas GF, Hadley AG, Nance SJ, Garratty G. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test. Transfusion 1993; 33: 484 7.en_US
dc.identifier.citedreferenceSacks DA, Nance SJ, Garratty G, et al. Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn. Am J Perinatol 1993; 10: 428 31.en_US
dc.identifier.citedreferenceHadley AG, Wilkes A, Goodrick J, et al. The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn. Br J Obstet Gynaecol 1998; 105: 231 4.en_US
dc.identifier.citedreferenceBowman JM. Hemolytic disease of the newborn. Vox Sang 1996; 70: 62 7.en_US
dc.identifier.citedreferenceOepkes D van Kemp IL, Simon MJG, et al. Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization. Am J Obstetr Gynecol 2001; 184: 1015 20.en_US
dc.identifier.citedreferenceAvent ND, Finning KM, Martin PG, Soothill PW. Prenatal determination of fetal blood group status. Vox Sang 2000; 78: 155 62.en_US
dc.identifier.citedreferenceVan Den Veyver IB, Subramanian SB, Hudson KM, et al. Prenatal diagnosis of the RhD fetal blood type on amniotic fluid by polymerase chain reaction. Obstet Gynecol 1996; 87: 419 22.en_US
dc.identifier.citedreferenceNess PM, Salamon JL. The failure of postinjection Rh immune globulin titers to detect large fetal-maternal hemorrhages. Am J Clin Pathol 1986; 85: 604 6.en_US
dc.identifier.citedreferenceKleihauer E, Betke K. [Practical application of the detection of HbF-containing cells in fixed blood smears]. Internist 1960; 1: 292 6.en_US
dc.identifier.citedreferenceLubenko A, Williams M, Johnson A, et al. Monitoring the clearance of fetal RhD-positive red cells in FMH following RhD immunoglobulin administration. Transfus Med 1999; 9: 331 5.en_US
dc.identifier.citedreferenceRiley JZ, Ness PM, Taddie SJ, et al. Detection and quantitation of fetal maternal hemorrhage utilizing an enzyme-linked antiglobulin test. Transfusion 1982; 22: 472 4.en_US
dc.identifier.citedreference44. Practice parameter: management of hyperbiliruinemaia in the healthy term newborn. American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Pediatrics 1994; 94: 558 65.en_US
dc.identifier.citedreference45. Joint Commission on Accreditation of Healthcare Organizations, Sentinel Event Alert. Issue 18: Kernicterus threatens healthy newborns. April 2001: ( http://www.jcaho.org/edupub/sealert/sea18.html ).en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1537-2995.2001.41111445.x.pdf
Size:
84.71KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.